{"id":"W2070826508","doi":"10.1158/0008-5472.sabcs-4116","title":"Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Bevacizumab; Internal medicine; Clinical endpoint; Hazard ratio; Docetaxel; Population; Neutropenia; Taxane; Placebo; Breast cancer; Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000955502,0.0004473464,0.0009939569,0.0001357646,0.0001477481,0.0006846625,0.0004395881,0.0005920725,0.001380455],"category_scores_gemma":[0.001291419,0.0002695696,0.0008830004,0.0002272411,0.0002416732,0.0003214111,0.0002265173,0.001445133,0.0002766929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005796144,"about_ca_system_score_gemma":0.0006676882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00131312,"about_ca_topic_score_gemma":0.003279133,"domain_scores_codex":[0.9996817,0.000174707,0.00002048093,0.00005110428,0.00003667815,0.00003528003],"domain_scores_gemma":[0.9993025,0.0001568934,0.0002603441,0.00003439495,0.00003475295,0.0002110634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8023592,0.009261847,0.03037348,0.001900238,0.002702525,0.0001982871,0.0002523095,0.001745822,0.01587163,0.0002162075,0.003650695,0.1314677],"study_design_scores_gemma":[0.4791092,0.4083928,0.09827623,0.0002323978,0.002012098,0.0005238604,0.0001368499,0.001730864,0.002104017,0.0002680564,0.007165586,0.00004804937],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906736,0.005829103,0.0002572723,0.00023898,0.00007746064,0.0004710671,0.0009163,0.00002783713,0.001508419],"genre_scores_gemma":[0.9953693,0.001934023,0.0003116742,0.0003475624,0.00008767881,0.0003278723,0.00092166,0.000008331627,0.0006919349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001380455,"threshold_uncertainty_score":0.005053282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08245026851302782,"score_gpt":0.450173094100438,"score_spread":0.3677228255874102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}